Meet the Team Behind This Evidence Review

Filler assessment · over-filling and reversal · evidence review

Dr. Ke He is Deputy Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital and head of its skin and laser aesthetic service — and she is the lead physician of this site. A core specialist formerly at the Plastic and Aesthetic Surgery Department of Xinqiao Hospital, affiliated with Army Medical University, she has worked on the clinical front line in skin laser and injectable aesthetics for more than 20 years, serving over ten thousand patients.

Her practice is non-surgical, and that is where this subject lands: she assesses a face at rest and in movement, asks what was placed and when, and works out whether the appearance the patient dislikes comes from accumulated volume, from a change in the skin, or from something that was never filler at all. She is explicit with patients about the two questions this review turns on — that the term describes a look rather than a condition, and that only one substance class can be dissolved. Where the honest answer is that nothing should be added, she says so, and where a face needs an operation rather than a needle she refers it.

Clinical focus

• Assessment of a face with an uncertain history of previous treatment
• Distinguishing accumulated volume from skin change and from tissue descent
• Hyaluronic-acid and non-hyaluronic-acid fillers, by zone and by layer
• Honest reporting of what the evidence supports and where it is thin
• Referral for surgical assessment where an operation is the honest answer

Academic roles & achievements

• Member, Laser Medicine Group, Chinese Medical Association Plastic Surgery Branch
• Member, Facial Rejuvenation Group, Chinese Medical Association Plastic Surgery Branch
• Member, Chongqing Plastic Surgery Quality Control Center
• Published 5 papers, holds 5 national patents, and introduced 2 new clinical techniques

Center leadership · surgical standards

Dr. Shaoliang Wang is Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team he provides the surgical perspective and the tertiary-hospital backstop — the assessment when an operation is the honest answer, and the hospital-level care for the rare complication that needs it.

For a reader of this review, his role is the guarantee that an individual assessment sits inside a departmental system rather than beside it: standardised assessment where an operation is considered, hospital support in the building, and a follow-up schedule that continues after treatment rather than ending with it.

Clinical focus

• Center leadership and multidisciplinary case review
• Surgical assessment when an operation is the honest answer to descent or excess skin
• Hospital-based care for the rare complication that needs theatre-level management

Aesthetic surgery · facial contouring · fat transfer

Dr. Tongchun Mao is an aesthetic surgeon within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is refinement and honest referral: he is the person who says so when an operation will do better than an injectable or a device.

Within this team his role is the surgical assessment of a face whose appearance is produced by tissue descent or laxity rather than by volume, and the comparison between restoring volume with filler and restoring it with the patient's own fat. Those are questions with trade-offs, and the assessment is where they are weighed rather than assumed.

Clinical focus

• Aesthetic surgical assessment and refinement of contour and asymmetry
• Honest referral when surgery outperforms a course of injections
• Shared case planning within the four-physician team

Dermatology · skin quality · barrier

Dr. Yongbo Jia is a dermatologist within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is medical skin assessment — diagnosing and managing pigment and barrier conditions, and treating skin that a device or an injection has irritated.

Within the team his role is the skin itself: whether what a patient reads as filler-related is in fact a change in skin quality, pigment or barrier, and what is contributing to it. It is a separate assessment from the volume question, and it is treated separately for that reason.

Clinical focus

• Medical skin assessment behind injectable treatment plans
• Diagnosis and management of pigment and barrier conditions
• Dermatologic care of skin after irritation or a delayed reaction